(Q66080164)

English

A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine

clinical trial

In more languages

edit

Statements

instance of

clinical trial

0 references

title

Phase 2 Randomized, Controlled, Human Influenza A (H1N1) Challenge Study Following Administration of an Oral H1N1 HA Adenoviral-Vector Based Seasonal Influenza Vaccine and dsRNA Adjuvant to Healthy Adult Volunteers (English)

0 references

country

United States of America

0 references

start time

31 August 2016

0 references

end time

19 May 2017

0 references

number of participants

179

0 references

clinical trial phase

phase II clinical trial

0 references

minimum age

18 year

0 references

maximum age

49 year

0 references

study type

interventional study

0 references

Identifiers

ClinicalTrials.gov ID

NCT02918006

0 references

(Q66080164)

A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)